Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000143.xml
kleintier konkret 2017; 20(05): 2-8
DOI: 10.1055/s-0043-110062
DOI: 10.1055/s-0043-110062
hund
gynäkologie
Mammatumoren beim Hund – Teil 2: Ein Überblick über Diagnostik und Therapie
Further Information
Publication History
Publication Date:
25 October 2017 (online)
![](https://www.thieme-connect.de/media/kleintier/201705/lookinside/thumbnails/10-1055-s-0043-110062_krastel-1.jpg)
Mammatumore gehören zu den häufigsten Tumorerkrankungen der Hündin. Der 2. Teil des Beitrags gibt einen Überblick über weiterführende Diagnostik, Therapiemöglichkeiten und Prognose der Erkrankung in Abhängigkeit von Tumorhistologie und -stadium (Teil 1: kleintier.konkret 2017; 4: 10–16).
-
Literatur
- 1 Arenas C, Pena L, Granados-Soler JL. et al. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study. Vet Rec 2016; 179 (5): 125
- 2 Cassali GD, Gobbi H, Malm C. et al. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours. Cytopathology 2007; 18 (3): 191-196
- 3 Chang SC, Chang CC, Chang TJ. et al. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998–2002). J Am Vet Med Assoc 2005; 227 (10): 1625-1629
- 4 Clemente M, Pérez-Alenza MD, Pena L. Metastasis of canine inflammatory versus non-inflammatory mammary tumours. J Comp Pathol 2010; 143 (2–3): 157-163
- 5 Clemente M, De Andrés PJ, Pena L. et al. Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy. Vet Rec 2009; 165 (3): 78-81
- 6 Mac Ewen EG, Harvey HJ, Patnaik AK. et al. Evaluation of effects of levamisole and surgery on canine mammary cancer. J Biol Response Mod 1985; 4 (4): 418-426
- 7 Karayannopoulou M, Kaldrymidou E, Constantinidis TC. et al. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. J Comp Pathol 2005; 133 (4): 246-252
- 8 Karayannopoulou M, Kaldrymidou E, Constantinidis TC. et al. Adjuvant post-operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 2001; 48 (2): 85-96
- 9 Kristiansen VM, Pena L, Diez Córdova L. et al. Effect of ovariohysterectomy at the time of tumor removal in dogs with mammary carcinomas: a randomized controlled trial. J Vet Intern Med 2016; 30 (1): 230-241
- 10 Kristiansen VM, Nodtvedt A, Breen AM. et al. Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial. J Vet Intern Med 2013; 27 (4): 935-942
- 11 Kurzman ID, Gilbertson SR. Prognostic factors in canine mammary tumors. Semin Vet Med Surg (Small Anim) 1986; 1 (1): 25-32
- 12 Lavalle GE, De Campos CB, Bertagnolli AC. et al. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors. In Vivo 2012; 26 (3): 375-379
- 13 Lurie DM, Seguin B, Schneider PD. et al. Contrast-assisted ultrasound for sentinel lymph node detection in spontaneously arising canine head and neck tumors. Invest Radiol 2006; 41 (4): 415-421
- 14 Marconato L, Romanelli G, Stefanello D. et al. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003–2008). J Am Vet Med Assoc 2009; 235 (8): 967-972
- 15 Marconato L, Lorenzo RM, Abramo F. et al. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs. Vet Comp Oncol 2008; 6 (2): 90-101
- 16 Misdorp W, Hart AA. Prognostic factors in canine mammary cancer. J Natl Cancer Inst 1976; 56 (4): 779-786
- 17 Misdorp W, Herder BA den. Bone metastasis in mammary cancer. A report of 10 cases in the female dog and some comparison with human cases Br J Cancer 1966; 20 (3): 496-503
- 18 Morris JS, Dobson JM, Bostock DE. et al. Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet Rec 1998; 142 (24): 656-658
- 19 De las Mulas JM, Millán Y, Dios R. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Vet Pathol 2005; 42 (2): 200-112
- 20 Nieto A, Pena L, Pérez-Alenza MD. et al. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol 2000; 37 (3): 239-247
- 21 Pena L, De Andrés PJ, Clemente M. et al. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics. Vet Pathol 2013; 50 (1): 94-105
- 22 Pereira CT, Luiz Navarro MF, Williams J. et al. 99mTc-labeled dextran for mammary lymphoscintigraphy in dogs. Vet Radiol Ultrasound 2008; 49 (5): 487-491
- 23 Pereira CT, Rahal SC, de Carvalho Balieiro JC. et al. Lymphatic drainage on healthy and neoplasic mammary glands in female dogs: can it really be altered?. Anat Histol Embryol 2003; 32 (5): 282-290
- 24 Philibert JC, Snyder PW, Glickman N. et al. Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med 2003; 17 (1): 102-106
- 25 Queiroga FL, Perez-Alenza MD, Silvan G. et al. Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance. Anticancer Res 2005; 25 (6B): 4269-4275
- 26 Rutteman GR. Mammatumoren. In: Kessler M. Hrsg. Kleintieronkologie. 2 Ausg. Stuttgart: Enke; 2005: 237-248
- 27 Rutteman GR, Withrow S, MacEwen E. Tumors of the mammary gland. In: Withrow SJ, Vail DM, Page RL. eds. Small Animal Clinical Oncology. 5th ed. St. Louis: Elsevier Saunders; 2013
- 28 Schneider R, Dorn CR, Taylor DO. Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst 1969; 43 (6): 1249-1261
- 29 Shofer FS, Sonnenschein EG, Goldschmidt MH. et al. Histopathologic and dietary prognostic factors for canine mammary carcinoma. Breast Cancer Res Treat 1989; 13 (1): 49-60
- 30 Simon D, Schoenrock D, Nolte I. et al. Cytologic examination of fine-needle aspirates from mammary gland tumors in the dog: diagnostic accuracy with comparison to histopathology and association with postoperative outcome. Vet Clin Pathol 2009; 38 (4): 521-528
- 31 Simon D, Schoenrock D, Baumgärtner W. et al. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel. J Vet Intern Med 2006; 20 (5): 1184-1190
- 32 Sorenmo KU, Worley DR, Goldschmidt MH. Tumors of the mammary gland. In: Withrow SJ, Vail DM, Page RL. eds. Small Animal Clinical Oncology. 5th ed. St. Louis: Elsevier Saunders; 2013: 538-556
- 33 Sorenmo KU, Kristiansen VM, Cofone MA. et al. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol 2009; 7 (3): 162-172
- 34 Sorenmo KU, Shofer FS, Goldschmidt MH. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med 2000; 14 (3): 266-270
- 35 de M Souza CH, Toledo-Piza E, Amorin R. et al. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. Can Vet J 2009; 50 (5): 506-510
- 36 Stratmann N, Failing K, Richter A. et al. Mammary tumor recurrence in bitches after regional mastectomy. Vet Surg 2008; 37 (1): 82-86
- 37 Tran CM, Moore AS, Frimberger AE. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy. Vet Comp Oncol 2016; 14 (3): 252-262
- 38 Tuohy JL, Milgram J, Worley DR. et al. A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology. Vet Comp Oncol 2009; 7 (2): 81-91
- 39 Yamagami T, Kobayashi T, Takahashi K. et al. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. J Vet Med Sci 1996; 58 (11): 1079-1083
- 40 Yamagami T, Kobayashi T, Takahashi K. et al. Influence of ovariectomy at the time of mastectomy on the prognosis for canine malignant mammary tumours. J Small Anim Pract 1996; 37 (10): 462-464